225 related articles for article (PubMed ID: 34253864)
1. Altered cortical thickness development in 22q11.2 deletion syndrome and association with psychotic symptoms.
Bagautdinova J; Zöller D; Schaer M; Padula MC; Mancini V; Schneider M; Eliez S
Mol Psychiatry; 2021 Dec; 26(12):7671-7678. PubMed ID: 34253864
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome.
Ramanathan S; Mattiaccio LM; Coman IL; Botti JC; Fremont W; Faraone SV; Antshel KM; Kates WR
Schizophr Res; 2017 Oct; 188():35-41. PubMed ID: 27988073
[TBL] [Abstract][Full Text] [Related]
3. Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.
Bakker G; Caan MW; Vingerhoets WA; da Silva-Alves F; de Koning M; Boot E; Nieman DH; de Haan L; Bloemen OJ; Booij J; van Amelsvoort TA
PLoS One; 2016; 11(11):e0159928. PubMed ID: 27828960
[TBL] [Abstract][Full Text] [Related]
4. Structural abnormalities in cortical volume, thickness, and surface area in 22q11.2 microdeletion syndrome: Relationship with psychotic symptoms.
Jalbrzikowski M; Jonas R; Senturk D; Patel A; Chow C; Green MF; Bearden CE
Neuroimage Clin; 2013; 3():405-15. PubMed ID: 24273724
[TBL] [Abstract][Full Text] [Related]
5. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.
Sun D; Ching CRK; Lin A; Forsyth JK; Kushan L; Vajdi A; Jalbrzikowski M; Hansen L; Villalon-Reina JE; Qu X; Jonas RK; van Amelsvoort T; Bakker G; Kates WR; Antshel KM; Fremont W; Campbell LE; McCabe KL; Daly E; Gudbrandsen M; Murphy CM; Murphy D; Craig M; Vorstman J; Fiksinski A; Koops S; Ruparel K; Roalf DR; Gur RE; Schmitt JE; Simon TJ; Goodrich-Hunsaker NJ; Durdle CA; Bassett AS; Chow EWC; Butcher NJ; Vila-Rodriguez F; Doherty J; Cunningham A; van den Bree MBM; Linden DEJ; Moss H; Owen MJ; Murphy KC; McDonald-McGinn DM; Emanuel B; van Erp TGM; Turner JA; Thompson PM; Bearden CE
Mol Psychiatry; 2020 Aug; 25(8):1822-1834. PubMed ID: 29895892
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Cortical Morphometry in the 22q11.2 Deletion Syndrome.
Schmitt JE; Vandekar S; Yi J; Calkins ME; Ruparel K; Roalf DR; Whinna D; Souders MC; Satterwaite TD; Prabhakaran K; McDonald-McGinn DM; Zackai EH; Gur RC; Emanuel BS; Gur RE
Biol Psychiatry; 2015 Jul; 78(2):135-43. PubMed ID: 25555483
[TBL] [Abstract][Full Text] [Related]
7. Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study.
Schaer M; Debbané M; Bach Cuadra M; Ottet MC; Glaser B; Thiran JP; Eliez S
Schizophr Res; 2009 Dec; 115(2-3):182-90. PubMed ID: 19836927
[TBL] [Abstract][Full Text] [Related]
8. Positive psychotic symptoms are associated with divergent developmental trajectories of hippocampal volume during late adolescence in patients with 22q11DS.
Mancini V; Sandini C; Padula MC; Zöller D; Schneider M; Schaer M; Eliez S
Mol Psychiatry; 2020 Nov; 25(11):2844-2859. PubMed ID: 31164700
[TBL] [Abstract][Full Text] [Related]
9. Elevated regional cerebral blood flow in adults with 22q11.2 deletion syndrome.
Pasternak M; Shirzadi Z; Mutsaerts HJMM; Boot E; Butcher NJ; MacIntosh BJ; Heung T; Bassett AS; Masellis M
World J Biol Psychiatry; 2023 Mar; 24(3):260-265. PubMed ID: 35748435
[TBL] [Abstract][Full Text] [Related]
10. Cortical morphology development in patients with 22q11.2 deletion syndrome at ultra-high risk of psychosis.
Padula MC; Schaer M; Armando M; Sandini C; Zöller D; Scariati E; Schneider M; Eliez S
Psychol Med; 2018 Oct; 48(14):2375-2383. PubMed ID: 29338796
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal study of premorbid adjustment in 22q11.2 deletion (velocardiofacial) syndrome and association with psychosis.
Radoeva PD; Fremont W; Antshel KM; Kates WR
Dev Psychopathol; 2017 Feb; 29(1):93-106. PubMed ID: 26864886
[TBL] [Abstract][Full Text] [Related]
12. Neural substrates of psychosis revealed by altered dependencies between brain activity and white-matter architecture in individuals with 22q11 deletion syndrome.
Bortolin K; Delavari F; Preti MG; Sandini C; Mancini V; Mullier E; Van De Ville D; Eliez S
Neuroimage Clin; 2022; 35():103075. PubMed ID: 35717884
[TBL] [Abstract][Full Text] [Related]
13. Cortical-amygdala volumetric ratios predict onset of symptoms of psychosis in 22q11.2 deletion syndrome.
Berhanu D; Mattiaccio LM; Antshel KM; Fremont W; Middleton FA; Kates WR
Psychiatry Res Neuroimaging; 2017 Jan; 259():10-15. PubMed ID: 27918911
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study of cerebral surface morphology in youth with 22q11.2 deletion syndrome, and association with positive symptoms of psychosis.
Radoeva PD; Bansal R; Antshel KM; Fremont W; Peterson BS; Kates WR
J Child Psychol Psychiatry; 2017 Mar; 58(3):305-314. PubMed ID: 27786353
[TBL] [Abstract][Full Text] [Related]
15. Altered structural network architecture is predictive of the presence of psychotic symptoms in patients with 22q11.2 deletion syndrome.
Padula MC; Scariati E; Schaer M; Sandini C; Ottet MC; Schneider M; Van De Ville D; Eliez S
Neuroimage Clin; 2017; 16():142-150. PubMed ID: 28794975
[TBL] [Abstract][Full Text] [Related]
16. Dysmaturation Observed as Altered Hippocampal Functional Connectivity at Rest Is Associated With the Emergence of Positive Psychotic Symptoms in Patients With 22q11 Deletion Syndrome.
Delavari F; Sandini C; Zöller D; Mancini V; Bortolin K; Schneider M; Van De Ville D; Eliez S
Biol Psychiatry; 2021 Jul; 90(1):58-68. PubMed ID: 33771350
[TBL] [Abstract][Full Text] [Related]
17. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.
Vorstman JA; Breetvelt EJ; Duijff SN; Eliez S; Schneider M; Jalbrzikowski M; Armando M; Vicari S; Shashi V; Hooper SR; Chow EW; Fung WL; Butcher NJ; Young DA; McDonald-McGinn DM; Vogels A; van Amelsvoort T; Gothelf D; Weinberger R; Weizman A; Klaassen PW; Koops S; Kates WR; Antshel KM; Simon TJ; Ousley OY; Swillen A; Gur RE; Bearden CE; Kahn RS; Bassett AS;
JAMA Psychiatry; 2015 Apr; 72(4):377-85. PubMed ID: 25715178
[TBL] [Abstract][Full Text] [Related]
18. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
[TBL] [Abstract][Full Text] [Related]
19. Frontal dysconnectivity in 22q11.2 deletion syndrome: an atlas-based functional connectivity analysis.
Mattiaccio LM; Coman IL; Thompson CA; Fremont WP; Antshel KM; Kates WR
Behav Brain Funct; 2018 Jan; 14(1):2. PubMed ID: 29352808
[TBL] [Abstract][Full Text] [Related]
20. Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness.
Ching CRK; Gutman BA; Sun D; Villalon Reina J; Ragothaman A; Isaev D; Zavaliangos-Petropulu A; Lin A; Jonas RK; Kushan L; Pacheco-Hansen L; Vajdi A; Forsyth JK; Jalbrzikowski M; Bakker G; van Amelsvoort T; Antshel KM; Fremont W; Kates WR; Campbell LE; McCabe KL; Craig MC; Daly E; Gudbrandsen M; Murphy CM; Murphy DG; Murphy KC; Fiksinski A; Koops S; Vorstman J; Crowley TB; Emanuel BS; Gur RE; McDonald-McGinn DM; Roalf DR; Ruparel K; Schmitt JE; Zackai EH; Durdle CA; Goodrich-Hunsaker NJ; Simon TJ; Bassett AS; Butcher NJ; Chow EWC; Vila-Rodriguez F; Cunningham A; Doherty J; Linden DE; Moss H; Owen MJ; van den Bree M; Crossley NA; Repetto GM; Thompson PM; Bearden CE
Am J Psychiatry; 2020 Jul; 177(7):589-600. PubMed ID: 32046535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
